The team led by John Tsang, an immunobiologist from Yale...
Category:
Health
Latest
China not to include Pfizer Inc’s Covid drug in its insurance scheme
Boxes of Paxlovid are changing hands for as much as 50,000 yuan...
Nurturing Talents: Compensation for Indian Workforce
Though western countries are embracing and adopting the concept of...
Proportion of youth with COVID-19 triples in five months: WHO
An analysis by the WHO of 6 million infections between Feb. 24 and July 12 found that the share of people aged 15-24 years rose to 15% from 4.5%.
Apart from the United States which leads a global tally with 4.8 million total cases, European countries including Spain, Germany and France, and Asian countries such as Japan, have said that many of the newly infected are young people.
“Younger people tend to be less vigilant about masking and social distancing,” Neysa Ernst, nurse manager at Johns Hopkins Hospital’s biocontainment unit in Baltimore, Maryland told Reuters in an email.
Zydus Cadila’s COVID-19 vaccine candidate found safe in early-stage human trial
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially, the company’s chairman told Reuters last month.
India reported a daily jump of more than 50,000 coronavirus infections for the seventh straight day on Wednesday.Total cases now stand at 1.91 million, the third biggest, after the United States and Brazil
The Pandemic workday Is 48 minutes longer and has more meetings
The researchers compared employee behavior over two 8 week periods before and after Covid-19 lockdowns. Looking at email and meeting meta-data, the group calculated the workday lasted 48.5 minutes longer, the number of meetings increased about 13% and people sent an average of 1.4 more emails per day to their colleagues.
“People have adjusted their work patterns,” said Jeff Polzer, a professor in the organizational behavior department at Harvard Business School, one of the study’s five co-authors.
90% of recovered COVID-19 patients in Wuhan suffering from lung damage:report
According to the first phase results, 90 per cent of the patients” lungs are still in a damaged state, which means their lungs ventilation and gas exchange functions have not recovered to the level of healthy people, state-run Global Times reported.
Some recovered patients have to rely on oxygen machines even three months after being discharged from the hospital, Liang Tengxiao, a doctor from the Dongzhimen Hospital, Beijing University of Chinese Medicine, was quoted as saying by the report.
Let Ayushman Bharat guide states to fix the cost of Covid -19 treatment,Centre to SC
CJI Bobde asked the government to urge insurance companies to release dues promptly.
“When there is a pandemic, insurance companies cannot keep their hands off,” he said.
Indian pharma majors race ahead to launch affordable drugs for Covid-19 treatment
Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied.
Drug firm BDR Pharmaceuticals on Wednesday said it has launched its antiviral drug Favipiravir for the treatment of COVID-19 patients in India at a price of Rs 63 per tablet.
Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name ‘Covihalt’ for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.
COVID-19 tally rises to 18,55,745, recoveries cross 12-lakh mark in India
The death toll due to COVID-19 climbed to 38,938 with 803 fresh fatalities being reported in 24-hours, the data updated at 8 am showed.
A total of 12,30,509 people have recovered, while there are 5,86,298 active cases of coronavirus infection in the country presently.
The recovery rate among COVID-19 patients has risen to 66.31 per cent, while the fatality rate has further dropped to 2.10 pc, the data stated.
Disburse pension to elderly on time; provide PPE, face masks to people in old age homes:SC
A bench headed by Justice Ashok Bhushan said this while hearing a plea filed by former Union minister and senior advocate Ashwani Kumar who said that at the time of the pandemic, it is necessary that pension to elderly reaches them on time.
Kumar told the top court that crores of elderly people are living alone and appropriate direction should be issued that pension reaches to those, who are already identified and eligible for it, on time.
Are pharma companies are trying to profiteer from Covid-19 vaccines
If a vaccine proves too expensive or difficult to obtain, those who seek exorbitant profits off of it will be scrutinized far more closely than bankers were after the 2008 crash. Actions like those that have already allowed insiders to pocket $80 million will provoke public revulsion, even if those trades were pre-scheduled. Calls to regulate sectors that take for granted intellectual property protections will grow exponentially. Those demands won’t be fanatical or radical, but mainstream.
India ‘flying blind’, needs better data collection to control Covid-19
India’s death registration data was patchy even before the virus struck. The vast majority of deaths, especially in rural villages, take place at home and routinely go unregistered. For others the cause of death listed is often anodyne — old age or heart attack. Experts believe that only between 20 per cent-30 per cent of all deaths in India are properly medically certified.